Fidelity Investments’s Bionano Genomics BNGO Stock Holding History

Fidelity Investments’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7	Buy	+6	New	+$8	﹤0.01%	5382
2025 Q2	–	Sell	-2	Closed	-$6	–	5338
2025 Q1	$6	Sell	2 -5	-71%	-$33	﹤0.01%	5257
2024 Q4	$118	Sell	7 -6	-46%	-$103	﹤0.01%	5088
2024 Q3	$351	Sell	13 -30	-70%	-$933	﹤0.01%	5000
2024 Q2	$1.77K	Sell	43 -11	-20%	-$605	﹤0.01%	4744
2024 Q1	$3.6K	Sell	54 -839	-94%	-$62.6K	﹤0.01%	4594
2023 Q4	$101K	Buy	893 +533	+148%	+$55.7K	﹤0.01%	3212
2023 Q3	$65.5K	Buy	360 +353	+5,043%	+$92.5K	﹤0.01%	3263
2023 Q2	$2.74K	Sell	7 -3	-30%	-$1.35K	﹤0.01%	4517
2023 Q1	$6.58K	Sell	10 -23	-70%	-$20.4K	﹤0.01%	4292
2022 Q4	$29.1K	Sell	33 -85	-72%	-$107K	﹤0.01%	3644
2022 Q3	$130K	Sell	118 -31	-21%	-$41K	﹤0.01%	3186
2022 Q2	$123K	Sell	149 -31	-17%	-$31.9K	﹤0.01%	3257
2022 Q1	$278K	Buy	+180	New	+$243K	﹤0.01%	3169
2021 Q4	–	Hold	0	–	–	–	4354
2021 Q3	–	Hold	0	–	–	–	4362
2021 Q2	–	Hold	0	–	–	–	4259
2021 Q1	–	Hold	0	–	–	–	3990

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Fidelity Investments's BNGO Position: Q1 2026 in Review

Fidelity Investments opened a new position in Bionano Genomics (BNGO) in Q1 2026: 6 shares worth $7. The stake represents ﹤0.01% of the portfolio and ranks #5382 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in BNGO as recently as Q1 2025.

Fidelity Investments first reported a position in BNGO in Q1 2022 and has held it in 14 quarters since. The position peaked at $278K in Q1 2022. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

Fidelity Investments held 6 shares of Bionano Genomics worth $7 as of Q1 2026.
Bionano Genomics was a new Fidelity Investments position in Q1 2026.
Bionano Genomics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5382 holding.
Fidelity Investments first reported a position in Bionano Genomics in Q1 2022 and has held it in 14 quarters since.
Fidelity Investments's Bionano Genomics position peaked at $278K in Q1 2022.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.